Medtronic: Scoop Up This Dividend Aristocrat On Sale Now
Portfolio Pulse from
Medtronic's shares have underperformed the S&P 500 recently, but the company has shown growth in revenue and non-GAAP EPS in its fiscal Q2. Medtronic holds an A credit rating from S&P with a stable outlook.
January 08, 2025 | 12:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Medtronic's shares have underperformed the S&P 500, but the company has shown growth in revenue and non-GAAP EPS in its fiscal Q2. Medtronic holds an A credit rating from S&P with a stable outlook.
Medtronic's recent underperformance relative to the S&P 500 may present a buying opportunity, especially given its revenue and EPS growth in fiscal Q2. The A credit rating from S&P with a stable outlook further supports the company's financial health, making it an attractive option for investors seeking stability and growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100